EMC Capital Management Sells 12,977 Shares of Sabra Healthcare REIT, Inc. $SBRA

EMC Capital Management decreased its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 54.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,995 shares of the real estate investment trust’s stock after selling 12,977 shares during the quarter. EMC Capital Management’s holdings in Sabra Healthcare REIT were worth $203,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of SBRA. Dorsey Wright & Associates bought a new position in Sabra Healthcare REIT during the 2nd quarter valued at approximately $329,000. Nomura Asset Management Co. Ltd. grew its position in shares of Sabra Healthcare REIT by 2.6% in the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 336,100 shares of the real estate investment trust’s stock worth $6,198,000 after buying an additional 8,600 shares during the last quarter. Duff & Phelps Investment Management Co. increased its stake in shares of Sabra Healthcare REIT by 0.6% during the second quarter. Duff & Phelps Investment Management Co. now owns 2,549,438 shares of the real estate investment trust’s stock valued at $47,012,000 after buying an additional 16,069 shares during the period. Ontario Teachers Pension Plan Board bought a new position in shares of Sabra Healthcare REIT during the second quarter valued at approximately $634,000. Finally, Cetera Investment Advisers lifted its stake in Sabra Healthcare REIT by 2.1% in the second quarter. Cetera Investment Advisers now owns 107,152 shares of the real estate investment trust’s stock worth $1,976,000 after acquiring an additional 2,203 shares during the period. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have issued reports on SBRA. Wells Fargo & Company reduced their price objective on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 21st. Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Cantor Fitzgerald initiated coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target for the company. JMP Securities lifted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research report on Wednesday, August 6th. Finally, UBS Group initiated coverage on Sabra Healthcare REIT in a research report on Tuesday. They issued a “neutral” rating and a $20.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $20.67.

Sabra Healthcare REIT Stock Up 1.2%

Shares of Sabra Healthcare REIT stock opened at $18.81 on Wednesday. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $19.97. The firm has a market cap of $4.69 billion, a price-to-earnings ratio of 24.75, a PEG ratio of 1.10 and a beta of 0.84. The company has a 50-day moving average of $18.37 and a 200 day moving average of $18.33. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business had revenue of $190.04 million for the quarter, compared to analysts’ expectations of $193.44 million. During the same quarter in the prior year, the company earned $0.37 earnings per share. The business’s revenue was up 6.7% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 28th. Investors of record on Monday, November 17th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.4%. The ex-dividend date of this dividend is Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 166.67%.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.